Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD - AMENDMENT

LONDON--()--

FORM 8.3

Amendment to Purchases & Sales

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Full name of discloser:   Barclays PLC.
     
(b) Owner or controller of interest and short
  positions disclosed, if different from 1(a):  
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
  relevant securities this form relates:  
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
  offeror/offeree:  
(e) Date position held/dealing undertaken: 12 December 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
  disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:       Ordinary NPV
Interests   Short Positions
    Number   (%) Number   (%)
(1) Relevant securities owned
and/or controlled: 12,151,001 1.53% 14,139,354 1.78%
           
(2) Cash-settled derivatives:
13,911,990 1.75% 11,146,635 1.40%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,671,600 1.34% 11,091,600 1.40%
           
 
TOTAL: 36,734,591 4.62% 36,377,589 4.58%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Number of   Price per unit
security   securities  
ADR Purchase 34,931 16.6240 USD
ADR Sale 11,135 16.7011 USD
ADR Sale 23,796 16.5880 USD
Ordinary NPV Purchase 300 3,734.3333 JPY
Ordinary NPV Purchase 300 3,741.5000 JPY
Ordinary NPV Purchase 600 3,734.1666 JPY
Ordinary NPV Purchase 700 3,746.5714 JPY
Ordinary NPV Purchase 735 3,742.5142 JPY
Ordinary NPV Purchase 892 3,729.2601 JPY
Ordinary NPV Purchase 1,000 3,727.5000 JPY
Ordinary NPV Purchase 1,100 3,728.6363 JPY
Ordinary NPV Purchase 2,220 3,739.0581 JPY
Ordinary NPV Purchase 2,800 3,732.2142 JPY
Ordinary NPV Purchase 3,475 3,737.5974 JPY
Ordinary NPV Purchase 4,000 3,730.2375 JPY
Ordinary NPV Purchase 4,260 3,741.7826 JPY
Ordinary NPV Purchase 4,900 3,728.9163 JPY
Ordinary NPV Purchase 5,600 3,729.7446 JPY
Ordinary NPV Purchase 6,300 3,709.3650 JPY
Ordinary NPV Purchase 6,500 3,734.6538 JPY
Ordinary NPV Purchase 7,847 3,733.9598 JPY
Ordinary NPV Purchase 9,100 3,673.0000 JPY
Ordinary NPV Purchase 9,933 3,729.5579 JPY
Ordinary NPV Purchase 10,200 3,736.9656 JPY
Ordinary NPV Purchase 12,966 3,744.0000 JPY
Ordinary NPV Purchase 14,400 3,728.7638 JPY
Ordinary NPV Purchase 14,900 3,666.7315 JPY
Ordinary NPV Purchase 17,200 3,716.6279 JPY
Ordinary NPV Purchase 18,500 3,729.6524 JPY
Ordinary NPV Purchase 19,838 3,732.3176 JPY
Ordinary NPV Purchase 22,100 3,733.6606 JPY
Ordinary NPV Purchase 23,000 3,718.0217 JPY
Ordinary NPV Purchase 30,300 3,736.1402 JPY
Ordinary NPV Purchase 46,800 3,718.0000 JPY
Ordinary NPV Purchase 74,800 3,725.5882 JPY
Ordinary NPV Purchase 123,100 3,711.3021 JPY
Ordinary NPV Purchase 283,700 3,713.5364 JPY
Ordinary NPV Purchase 650,500 3,717.0387 JPY
Ordinary NPV Purchase 682,000 3,716.5464 JPY
Ordinary NPV Sale 31 3,685.6452 JPY
Ordinary NPV Sale 31 3,689.6451 JPY
Ordinary NPV Sale 166 3,685.0481 JPY
Ordinary NPV Sale 289 3,673.9180 JPY
Ordinary NPV Sale 304 3,689.5921 JPY
Ordinary NPV Sale 385 3,689.1740 JPY
Ordinary NPV Sale 600 3,734.1666 JPY
Ordinary NPV Sale 952 3,691.4936 JPY
Ordinary NPV Sale 1,000 3,727.5000 JPY
Ordinary NPV Sale 1,040 3,682.7798 JPY
Ordinary NPV Sale 1,102 3,694.0608 JPY
Ordinary NPV Sale 1,400 3,718.3571 JPY
Ordinary NPV Sale 1,679 3,690.4604 JPY
Ordinary NPV Sale 2,000 3,672.6000 JPY
Ordinary NPV Sale 2,800 3,673.0000 JPY
Ordinary NPV Sale 3,021 3,682.6521 JPY
Ordinary NPV Sale 4,000 3,730.2375 JPY
Ordinary NPV Sale 4,200 3,710.1428 JPY
Ordinary NPV Sale 4,600 3,733.5434 JPY
Ordinary NPV Sale 4,900 3,728.9163 JPY
Ordinary NPV Sale 5,600 3,729.7446 JPY
Ordinary NPV Sale 6,500 3,734.6538 JPY
Ordinary NPV Sale 6,600 3,707.2272 JPY
Ordinary NPV Sale 6,900 3,719.9710 JPY
Ordinary NPV Sale 7,900 3,700.0000 JPY
Ordinary NPV Sale 10,200 3,736.9656 JPY
Ordinary NPV Sale 14,300 3,728.6678 JPY
Ordinary NPV Sale 18,500 3,729.6524 JPY
Ordinary NPV Sale 30,100 3,717.7940 JPY
Ordinary NPV Sale 30,100 3,709.5647 JPY
Ordinary NPV Sale 30,600 3,736.1928 JPY
Ordinary NPV Sale 40,500 3,728.5061 JPY
Ordinary NPV Sale 55,300 3,718.0000 JPY
Ordinary NPV Sale 123,100 3,710.8091 JPY
Ordinary NPV Sale 452,100 3,715.1767 JPY
Ordinary NPV Sale 665,400 3,715.9122 JPY
Ordinary NPV Sale 674,100 3,716.7403 JPY

(b) Cash-settled derivative transactions

Class of   Product   Nature of dealing   Number of   Price per
relevant description reference unit
security     securities  
Ordinary NPV SWAP Long 31 3,685.6314 JPY
Ordinary NPV SWAP Long 31 3,689.6310 JPY
Ordinary NPV SWAP Long 166 3,685.0491 JPY
Ordinary NPV SWAP Long 289 3,673.9180 JPY
Ordinary NPV SWAP Long 304 3,689.5920 JPY
Ordinary NPV SWAP Long 385 3,689.1739 JPY
Ordinary NPV SWAP Long 952 3,691.4933 JPY
Ordinary NPV CFD Long 1,000 3,744.7760 JPY
Ordinary NPV SWAP Long 1,040 3,682.7807 JPY
Ordinary NPV SWAP Long 1,102 3,694.0615 JPY
Ordinary NPV SWAP Long 1,600 3,718.0000 JPY
Ordinary NPV SWAP Long 1,679 3,690.4599 JPY
Ordinary NPV SWAP Long 3,021 3,682.6523 JPY
Ordinary NPV SWAP Long 5,400 3,721.9807 JPY
Ordinary NPV CFD Long 6,000 3,672.6328 JPY
Ordinary NPV CFD Long 180,000 3,712.6072 JPY
Ordinary NPV SWAP Short 100 3,709.0000 JPY
Ordinary NPV SWAP Short 400 3,728.6250 JPY
Ordinary NPV SWAP Short 735 3,742.5140 JPY
Ordinary NPV SWAP Short 892 3,729.2608 JPY
Ordinary NPV SWAP Short 2,220 3,739.0587 JPY
Ordinary NPV SWAP Short 3,475 3,737.5978 JPY
Ordinary NPV SWAP Short 4,260 3,741.7830 JPY
Ordinary NPV SWAP Short 4,900 3,669.1651 JPY
Ordinary NPV SWAP Short 7,847 3,733.9599 JPY
Ordinary NPV SWAP Short 9,933 3,729.5579 JPY
Ordinary NPV SWAP Short 19,838 3,732.3176 JPY
Ordinary NPV CFD Short 45,000 3,718.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   YES
Date of disclosure: 14 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings   Barclays PLC.
are being disclosed:  
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:  

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class   Product   Writing,   Number   Exercise   Type   Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
      relates      
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Call Options Written -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Purchased -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Written 10,000,000 4206.0397 European 7 Jan 2019

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Category Code: RET
Sequence Number: 660998
Time of Receipt (offset from UTC): 20181214T121321+0000

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC